These vaccines were generated by intercalating di-phosphorylated melanoma peptide antigen Tyrosine-related protein 2 (pTRP2), and poly(IC) and mRNA derived from melanoma cells, which contain several phosphate groups in their backbone (Fig. S6). Here, DCT is linked to melanoma.